A detailed history of Bellevue Asset Management, LLC transactions in Inspire Md, Inc. stock. As of the latest transaction made, Bellevue Asset Management, LLC holds 15 shares of NSPR stock, worth $39. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15
Previous 19 21.05%
Holding current value
$39
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$2.36 - $3.39 $9 - $13
-4 Reduced 21.05%
15 $0
Q4 2023

Feb 06, 2024

BUY
$2.06 - $3.77 $8 - $15
4 Added 26.67%
19 $0
Q1 2023

May 09, 2023

SELL
$0.87 - $1.32 $1 - $2
-2 Reduced 11.76%
15 $0
Q2 2022

Aug 12, 2022

SELL
$1.89 - $3.27 $7 - $13
-4 Reduced 19.05%
17 $3,000
Q1 2022

May 11, 2022

SELL
$2.39 - $3.23 $9 - $12
-4 Reduced 16.0%
21 $5,000
Q4 2021

Feb 03, 2022

SELL
$2.93 - $4.35 $5 - $8
-2 Reduced 7.41%
25 $6,000
Q2 2021

Aug 09, 2021

BUY
$4.42 - $10.05 $119 - $271
27 New
27 $5,000

Others Institutions Holding NSPR

About InspireMD, Inc.


  • Ticker NSPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 8,323,200
  • Market Cap $22.1M
  • Description
  • InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system for use in carotid artery applic...
More about NSPR
Track This Portfolio

Track Bellevue Asset Management, LLC Portfolio

Follow Bellevue Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Asset Management, LLC with notifications on news.